Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Bronchial Asthma | Research article

Asthma rehabilitation at high vs. low altitude: randomized parallel-group trial

Authors: Stéphanie Saxer, Simon R. Schneider, Paula Appenzeller, Patrick R. Bader, Mona Lichtblau, Michael Furian, Ulan Sheraliev, Bermet Estebesova, Berik Emilov, Talant Sooronbaev, Konrad E. Bloch, Silvia Ulrich

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Background

To investigate the effect of asthma rehabilitation at high altitude (3100 m, HA) compared to low altitude (760 m, LA).

Methods

For this randomized parallel-group trial insufficiently controlled asthmatics (Asthma Control Questionnaire (ACQ) > 0.75) were randomly assigned to 3-week in-hospital rehabilitation comprising education, physical-&breathing-exercises at LA or HA. Co-primary outcomes assessed at 760 m were between group changes in peak expiratory flow (PEF)-variability, and ACQ) from baseline to end-rehabilitation and 3 months thereafter.

Results

50 asthmatics were randomized [median (quartiles) LA: ACQ 2.7(1.7;3.2), PEF-variability 19%(14;33); HA: ACQ 2.0(1.6;3.0), PEF-variability 17%(12;32)].
The LA-group improved PEF-variability by median(95%CI) -7%(− 14 to 0, p = 0.033), ACQ − 1.4(− 2.2 to − 0.9, p < 0.001), and after 3 months by − 3%(− 18 to 2, p = 0.103) and − 0.9(− 1.3 to − 0.3, p = 0.002). The HA-group improved PEF-variability by − 10%(− 21 to − 3, p = 0.004), ACQ − 1.1(− 1.3 to − 0.7, p < 0.001), and after 3 months by − 9%(− 10 to − 3, p = 0.003) and − 0.2(− 0.9 to 0.4, p = 0.177). The additive effect of HA vs. LA directly after the rehabilitation on PEF-variability was − 6%(− 14 to 2), on ACQ 0.3(− 0.4 to 1.1) and after 3 months − 5%(− 14 to 5) respectively 0.4(− 0.4 to 1.1), all p = NS.

Conclusion

Asthma rehabilitation is highly effective in improving asthma control in terms of PEF-variability and symptoms, both at LA and HA similarly.

Trial registration

Clinicaltrials.gov: NCT02741583, Registered April 18, 2016.
Appendix
Available only for authorised users
Literature
2.
go back to reference Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the innovative medicine initiative (IMI). Thorax. 2011;66(10):910–7.CrossRef Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the innovative medicine initiative (IMI). Thorax. 2011;66(10):910–7.CrossRef
5.
go back to reference Nathell L. Effects on sick leave of an inpatient rehabilitation programme for asthmatics in a randomized trial. Scand J Public Health. 2005;33(1):57–64.CrossRef Nathell L. Effects on sick leave of an inpatient rehabilitation programme for asthmatics in a randomized trial. Scand J Public Health. 2005;33(1):57–64.CrossRef
6.
go back to reference Grootendorst DC, Dahlen SE, Van Den Bos JW, Duiverman EJ, Veselic-Charvat M, Vrijlandt EJ, et al. Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy. 2001;31(3):400–8.CrossRef Grootendorst DC, Dahlen SE, Van Den Bos JW, Duiverman EJ, Veselic-Charvat M, Vrijlandt EJ, et al. Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy. 2001;31(3):400–8.CrossRef
7.
go back to reference Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Bel EH, Weersink EJ. High-altitude treatment in atopic and nonatopic patients with severe asthma. Eur Respir J. 2012;40(6):1374–80.CrossRef Rijssenbeek-Nouwens LH, Fieten KB, Bron AO, Hashimoto S, Bel EH, Weersink EJ. High-altitude treatment in atopic and nonatopic patients with severe asthma. Eur Respir J. 2012;40(6):1374–80.CrossRef
8.
go back to reference Rijssenbeek-Nouwens LH, Bel EH. High-altitude treatment: a therapeutic option for patients with severe, refractory asthma? Clin Exp Allergy. 2011;41(6):775–82.CrossRef Rijssenbeek-Nouwens LH, Bel EH. High-altitude treatment: a therapeutic option for patients with severe, refractory asthma? Clin Exp Allergy. 2011;41(6):775–82.CrossRef
9.
go back to reference Spieksma FT, Zuidema P, Leupen MJ. High altitude and house-dust mites. Br Med J. 1971;1(5740):82–4.CrossRef Spieksma FT, Zuidema P, Leupen MJ. High altitude and house-dust mites. Br Med J. 1971;1(5740):82–4.CrossRef
10.
go back to reference Platts-Mills TA, Chapman MD. Dust mites: immunology, allergic disease, and environmental control. J Allergy Clin Immunol. 1987;80(6):755–75.CrossRef Platts-Mills TA, Chapman MD. Dust mites: immunology, allergic disease, and environmental control. J Allergy Clin Immunol. 1987;80(6):755–75.CrossRef
11.
go back to reference Karagiannidis C, Hense G, Rueckert B, Mantel PY, Ichters B, Blaser K, et al. High-altitude climate therapy reduces local airway inflammation and modulates lymphocyte activation. Scand J Immunol. 2006;63(4):304–10.CrossRef Karagiannidis C, Hense G, Rueckert B, Mantel PY, Ichters B, Blaser K, et al. High-altitude climate therapy reduces local airway inflammation and modulates lymphocyte activation. Scand J Immunol. 2006;63(4):304–10.CrossRef
12.
go back to reference Renzetti G, Silvestre G, D'Amario C, Bottini E, Gloria-Bottini F, Bottini N, et al. Less air pollution leads to rapid reduction of airway inflammation and improved airway function in asthmatic children. Pediatrics. 2009;123(3):1051–8.CrossRef Renzetti G, Silvestre G, D'Amario C, Bottini E, Gloria-Bottini F, Bottini N, et al. Less air pollution leads to rapid reduction of airway inflammation and improved airway function in asthmatic children. Pediatrics. 2009;123(3):1051–8.CrossRef
13.
go back to reference Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest. 1995;96(5):2393–403.CrossRef Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest. 1995;96(5):2393–403.CrossRef
14.
go back to reference Haczku A, Panettieri RA Jr. Social stress and asthma: the role of corticosteroid insensitivity. J Allergy Clin Immunol. 2010;125(3):550–8.CrossRef Haczku A, Panettieri RA Jr. Social stress and asthma: the role of corticosteroid insensitivity. J Allergy Clin Immunol. 2010;125(3):550–8.CrossRef
15.
go back to reference Bosley CM, Corden ZM, Cochrane GM. Psychosocial factors and asthma. Respir Med. 1996;90(8):453–7.CrossRef Bosley CM, Corden ZM, Cochrane GM. Psychosocial factors and asthma. Respir Med. 1996;90(8):453–7.CrossRef
17.
go back to reference Juniper EF, Bousquet J, Abetz L, Bateman ED, Committee G. Identifying 'well-controlled' and 'not well-controlled' asthma using the asthma control questionnaire. Respir Med. 2006;100(4):616–21.CrossRef Juniper EF, Bousquet J, Abetz L, Bateman ED, Committee G. Identifying 'well-controlled' and 'not well-controlled' asthma using the asthma control questionnaire. Respir Med. 2006;100(4):616–21.CrossRef
18.
go back to reference Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–15.CrossRef Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–15.CrossRef
19.
go back to reference Sampson JB, Cymerman A, Burse RL, Maher JT, Rock PB. Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med. 1983;54(12 Pt 1):1063–73.PubMed Sampson JB, Cymerman A, Burse RL, Maher JT, Rock PB. Procedures for the measurement of acute mountain sickness. Aviat Space Environ Med. 1983;54(12 Pt 1):1063–73.PubMed
20.
go back to reference Bateman ED, Esser D, Chirila C, Fernandez M, Fowler A, Moroni-Zentgraf P, et al. Magnitude of effect of asthma treatments on asthma quality of life questionnaire and asthma control questionnaire scores: systematic review and network meta-analysis. J Allergy Clin Immunol. 2015;136(4):914–22.CrossRef Bateman ED, Esser D, Chirila C, Fernandez M, Fowler A, Moroni-Zentgraf P, et al. Magnitude of effect of asthma treatments on asthma quality of life questionnaire and asthma control questionnaire scores: systematic review and network meta-analysis. J Allergy Clin Immunol. 2015;136(4):914–22.CrossRef
21.
go back to reference Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1):103–15.CrossRef Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1):103–15.CrossRef
22.
go back to reference Huss-Marp J, Kramer U, Eberlein B, Pfab F, Ring J, Behrendt H, et al. Reduced exhaled nitric oxide values in children with asthma after inpatient rehabilitation at high altitude. J Allergy Clin Immunol. 2007;120(2):471–2.CrossRef Huss-Marp J, Kramer U, Eberlein B, Pfab F, Ring J, Behrendt H, et al. Reduced exhaled nitric oxide values in children with asthma after inpatient rehabilitation at high altitude. J Allergy Clin Immunol. 2007;120(2):471–2.CrossRef
23.
go back to reference Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390–413.CrossRef Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390–413.CrossRef
24.
go back to reference Trevor JL, Bhatt SP, Wells JM, Kirkpatrick d SC, Hitchcock J, et al. Benefits of completing pulmonary rehabilitation in patients with asthma. J Asthma. 2015;52(9):969–73.CrossRef Trevor JL, Bhatt SP, Wells JM, Kirkpatrick d SC, Hitchcock J, et al. Benefits of completing pulmonary rehabilitation in patients with asthma. J Asthma. 2015;52(9):969–73.CrossRef
25.
go back to reference Renolleau-Courtois D, Lamouroux-Delay A, Delpierre S, Badier M, Lagier-Tessonnier F, Palot A, et al. Home-based respiratory rehabilitation in adult patients with moderate or severe persistent asthma. J Asthma. 2014;51(5):552–8.CrossRef Renolleau-Courtois D, Lamouroux-Delay A, Delpierre S, Badier M, Lagier-Tessonnier F, Palot A, et al. Home-based respiratory rehabilitation in adult patients with moderate or severe persistent asthma. J Asthma. 2014;51(5):552–8.CrossRef
26.
go back to reference Carson KV, Chandratilleke MG, Picot J, Brinn MP, Esterman AJ, Smith BJ. Physical training for asthma. Cochrane Database Syst Rev. 2013;9:CD001116. Carson KV, Chandratilleke MG, Picot J, Brinn MP, Esterman AJ, Smith BJ. Physical training for asthma. Cochrane Database Syst Rev. 2013;9:CD001116.
27.
go back to reference Boyd A, Yang CT, Estell K, Ms CT, Gerald LB, Dransfield M, et al. Feasibility of exercising adults with asthma: a randomized pilot study. Allergy Asthma Clin Immunol. 2012;8(1):13.CrossRef Boyd A, Yang CT, Estell K, Ms CT, Gerald LB, Dransfield M, et al. Feasibility of exercising adults with asthma: a randomized pilot study. Allergy Asthma Clin Immunol. 2012;8(1):13.CrossRef
28.
go back to reference Constantini K, Wilhite DP, Chapman RF. A clinician guide to altitude training for optimal endurance exercise performance at sea level. High Alt Med Biol. 2017;18(2):93–101.CrossRef Constantini K, Wilhite DP, Chapman RF. A clinician guide to altitude training for optimal endurance exercise performance at sea level. High Alt Med Biol. 2017;18(2):93–101.CrossRef
Metadata
Title
Asthma rehabilitation at high vs. low altitude: randomized parallel-group trial
Authors
Stéphanie Saxer
Simon R. Schneider
Paula Appenzeller
Patrick R. Bader
Mona Lichtblau
Michael Furian
Ulan Sheraliev
Bermet Estebesova
Berik Emilov
Talant Sooronbaev
Konrad E. Bloch
Silvia Ulrich
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-0890-y

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue